BIOCRYST
BioCryst Pharmaceuticals, Inc.
Application Filed: 2007-08-14
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77254497 |
| Registration Number | 3974837 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Thomas G. Peterson |
| Attorney Docket Number | T01831US04 |
| Law Office Assigned | M40 |
| Employee Name | CHOE, KELLY |
Timeline
| 2007-08-14 | Application Filed |
| 2007-08-14 | Date of First Use |
| 2008-01-01 | Published for Opposition |
| 2011-06-07 | Trademark Registered |
| 2017-08-01 | Location: TMO LAW OFFICE 113 |
| 2017-08-01 | Status: Live/Registered |
| 2018-07-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BioCryst Pharmaceuticals, Inc. |
| Address | 4505 Emperor Blvd., Ste. 200 Durham DE 27703 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza [ and hepatitis ] ; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2007-08-17 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2007-11-21 | 2 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2007-11-23 | 3 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2007-11-23 | 4 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2007-11-23 | 5 GNEN O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2007-11-23 | 6 ALIE A:Allowance for Publication |
| EXAMINER'S AMENDMENT ENTERED | 2007-11-23 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2007-11-23 | 8 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2007-11-28 | 9 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2007-12-12 | 10 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2008-01-01 | 11 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2008-03-25 | 12 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2008-09-25 | 13 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2008-09-25 | 14 EXT1 S: |
| EXTENSION 1 GRANTED | 2008-09-25 | 15 EX1G S: |
| TEAS EXTENSION RECEIVED | 2009-03-24 | 16 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2009-04-08 | 17 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2009-03-24 | 18 EXT2 S: |
| EXTENSION 2 GRANTED | 2009-04-08 | 19 EX2G S: |
| TEAS EXTENSION RECEIVED | 2009-09-24 | 20 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2009-09-24 | 21 EXT3 S: |
| EXTENSION 3 GRANTED | 2009-09-29 | 22 EX3G S: |
| TEAS EXTENSION RECEIVED | 2010-03-25 | 23 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2010-03-25 | 24 EXT4 S: |
| EXTENSION 4 GRANTED | 2010-03-30 | 25 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-03-31 | 26 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2010-09-22 | 27 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2010-09-22 | 28 EXT5 S: |
| EXTENSION 5 GRANTED | 2010-09-27 | 29 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-09-28 | 30 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2011-03-23 | 31 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2011-03-23 | 32 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2011-03-25 | 33 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2011-04-14 | 34 CNPR P: |
| ASSIGNED TO LIE | 2011-04-30 | 35 ALIE A:Allowance for Publication |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2011-05-03 | 36 REGV O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2011-05-04 | 37 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-06-07 | 38 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2017-06-15 | 39 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-07-31 | 40 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2017-08-01 | 41 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2017-08-01 | 42 NA85 E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-07-12 | 43 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-06-07 | 44 REM2 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-16 | 45 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-16 | 46 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-16 | 47 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-16 | 48 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-16 | 49 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-05-06 | 50 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-05-06 | 51 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-05-06 | 52 TCCA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-21 | 53 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-21 | 54 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-21 | 55 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2021-12-06 | 56 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-04-04 | 57 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-04-04 | 58 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2022-04-04 | 59 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-04-04 | 60 NA89 E:E-Mail |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2023-05-03 | 61 ASCK I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BIOCRYST 88073891 5713814 Live/Registered |
BioCryst Pharmaceuticals, Inc. 2018-08-10 |
 BIOCRYST 77254503 4096431 Dead/Cancelled |
BioCryst Pharmaceuticals, Inc. 2007-08-14 |
 BIOCRYST 77254497 3974837 Live/Registered |
BioCryst Pharmaceuticals, Inc. 2007-08-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 